Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,525 | -11,764 | -6,857 | -4,842 | -1,836 |
| Depreciation Amortization | 79 | 192 | 125 | 69 | 32 |
| Accounts receivable | -285 | -890 | -747 | -293 | -95 |
| Other Working Capital | -479 | 1,229 | 533 | 919 | 686 |
| Other Operating Activity | 225 | 4,501 | 1,295 | 962 | -48 |
| Operating Cash Flow | $-1,984 | $-6,731 | $-5,652 | $-3,184 | $-1,261 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 2,192 | 2,192 | 1,943 | -298 |
| PPE Investments | -71 | -141 | -156 | -98 | -36 |
| Purchase Sale Intangibles | -134 | -455 | -342 | -212 | -71 |
| Other Investing Activity | -134 | -455 | -342 | -212 | -71 |
| Investing Cash Flow | $-205 | $1,597 | $1,695 | $1,632 | $-405 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,000 | 5,000 | 5,000 | N/A |
| Common Stock Issued | 176 | 183 | 130 | 29 | 28 |
| Other Financing Activity | 0 | -119 | -119 | -119 | 0 |
| Financing Cash Flow | $176 | $5,064 | $5,011 | $4,910 | $28 |
| Exchange Rate Effect | 7 | -1 | 4 | -5 | -141 |
| Beginning Cash Position | 5,245 | 5,317 | 5,317 | 5,317 | 5,317 |
| End Cash Position | 3,240 | 5,245 | 6,375 | 8,670 | 3,537 |
| Net Cash Flow | $-2,005 | $-72 | $1,058 | $3,354 | $-1,779 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,984 | -6,731 | -5,652 | -3,184 | -1,261 |
| Capital Expenditure | -71 | -141 | -156 | -98 | -36 |
| Free Cash Flow | -2,055 | -6,872 | -5,808 | -3,282 | -1,297 |